OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 34
Sanghyuk Yoon, Kihun Kim, Kihyuk Shin, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 52-61
Closed Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, et al.
Dermatology and Therapy (2025)
Open Access | Times Cited: 2
Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, et al.
Dermatology and Therapy (2025)
Open Access | Times Cited: 2
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis
Mingyue Wang, Xing‐Hua Gao, Li Zhang
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 88-97
Closed Access | Times Cited: 1
Mingyue Wang, Xing‐Hua Gao, Li Zhang
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 88-97
Closed Access | Times Cited: 1
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Amalie Thorsti Møller Rønnstad, Christopher G. Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology (2025)
Closed Access | Times Cited: 1
Amalie Thorsti Møller Rønnstad, Christopher G. Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology (2025)
Closed Access | Times Cited: 1
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 8
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 8
Comparative safety of oral Janus kinase inhibitors and dupilumab in patients with atopic dermatitis: a population-based cohort study
Serena Yun‐Chen Tsai, Wanda Phipatanakul, Elena B. Hawryluk, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 5, pp. 1195-1203.e3
Closed Access | Times Cited: 8
Serena Yun‐Chen Tsai, Wanda Phipatanakul, Elena B. Hawryluk, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 5, pp. 1195-1203.e3
Closed Access | Times Cited: 8
Association between Atopic Dermatitis and Dementia: Evidence from Systematic Review, Meta-analysis, and Mendelian Randomization
Yeon-Su Gwak, Seo-Yeon Kim, Chae-Eon Woo, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv41321-adv41321
Open Access
Yeon-Su Gwak, Seo-Yeon Kim, Chae-Eon Woo, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv41321-adv41321
Open Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Comparative Real-World Analysis of Baseline Demographic Characteristics and Comorbidities in Atopic Dermatitis Patients Initiating Biologics Versus JAK Inhibitors
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Husein Husein‐ElAhmed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1291-1291
Open Access
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Husein Husein‐ElAhmed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1291-1291
Open Access
Discovery of a new anti-γc antibody in clinical development for the treatment of autoimmune diseases
Chin Wai Hui, Wai Chung Wu, Tak Keung Tong, et al.
The Journal of Immunology (2025)
Closed Access
Chin Wai Hui, Wai Chung Wu, Tak Keung Tong, et al.
The Journal of Immunology (2025)
Closed Access
Age and Socioeconomic Deprivation as Key Predictors of Cardiovascular Risk in Patients With Autoimmune Rheumatic Diseases on JAK Inhibitors
Kehinde Sunmboye, B Nguyen Bui
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 3
Closed Access
Kehinde Sunmboye, B Nguyen Bui
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 3
Closed Access
Pulsatilla koreana Nakai Extract Attenuates Atopic Dermatitis-like Symptoms by Regulating Skin Barrier Factors and Inhibiting the JAK/STAT Pathway
Hye Jin Kim, Musun Park, Seol Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2994-2994
Open Access
Hye Jin Kim, Musun Park, Seol Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2994-2994
Open Access
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results
Lian F. van der Gang, Keneshka Atash, Nicolaas P. A. Zuithoff, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Open Access
Lian F. van der Gang, Keneshka Atash, Nicolaas P. A. Zuithoff, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Open Access
Off-label use of recombinant adjuvanted Herpes Zoster vaccine in a 10-year-old high-risk patient affected by epidermolysis bullosa: A case report
Claudia Palmieri, Chiara Noviello, Lorenza Moscara, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Claudia Palmieri, Chiara Noviello, Lorenza Moscara, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Cardiovascular safety of Janus kinase inhibitors: A pharmacovigilance study from 2012–2023
Xiaoyan Zhong, Jianchun Luo, Yuying Huang, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322849-e0322849
Open Access
Xiaoyan Zhong, Jianchun Luo, Yuying Huang, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322849-e0322849
Open Access
Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses
Qingying He, Xin Xie, Qian Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Qingying He, Xin Xie, Qian Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition
Martina Dragotto, Martina D’Onghia, Emanuele Trovato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3091-3091
Open Access | Times Cited: 3
Martina Dragotto, Martina D’Onghia, Emanuele Trovato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3091-3091
Open Access | Times Cited: 3
A Systematic Review and Meta-analysis of Mobile Health Applications and Telemonitoring in Atopic Dermatitis Self-Management
Iván Chérrez-Ojeda, Karla Robles‐Velasco, María F. Osorio, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1787-1798
Open Access | Times Cited: 2
Iván Chérrez-Ojeda, Karla Robles‐Velasco, María F. Osorio, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 7, pp. 1787-1798
Open Access | Times Cited: 2
Atopic dermatitis: pathogenesis and therapeutic intervention
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Chengcheng Yue, Hong Zhou, Xiaoyan Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 2
Successful treatment of nail lichen planus with tofacitinib: a case report and review of the literature
Jundong Huang, Wei Shi
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Jundong Huang, Wei Shi
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Nonsteroidal Approaches for Atopic Dermatitis: A Clinical Update
Peter Ch’en, Peter Lio
Dermatitis (2024)
Closed Access | Times Cited: 1
Peter Ch’en, Peter Lio
Dermatitis (2024)
Closed Access | Times Cited: 1
Novel investigational drugs for alopecia areata and future perspectives
Ivana Chim, Ragini Ghiya, Rodney Sinclair, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 441-449
Closed Access | Times Cited: 1
Ivana Chim, Ragini Ghiya, Rodney Sinclair, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 441-449
Closed Access | Times Cited: 1
The impact of assisted reproductive technologies on ADHD: A systematic review and meta-analysis
Seongbeen Hwang, Jin‐Young Jung, H.S. Moon, et al.
Asian Journal of Psychiatry (2024) Vol. 99, pp. 104125-104125
Closed Access | Times Cited: 1
Seongbeen Hwang, Jin‐Young Jung, H.S. Moon, et al.
Asian Journal of Psychiatry (2024) Vol. 99, pp. 104125-104125
Closed Access | Times Cited: 1
A review of comorbidities in atopic dermatitis
Ozlem Apti Sengkioun, Andaç Salman
Indian Journal of Skin Allergy (2024) Vol. 3, pp. 87-92
Closed Access | Times Cited: 1
Ozlem Apti Sengkioun, Andaç Salman
Indian Journal of Skin Allergy (2024) Vol. 3, pp. 87-92
Closed Access | Times Cited: 1
